219 related articles for article (PubMed ID: 16528918)
21. Recent advances in biomarkers for cancer diagnosis and treatment.
Manne U; Srivastava RG; Srivastava S
Drug Discov Today; 2005 Jul; 10(14):965-76. PubMed ID: 16023055
[TBL] [Abstract][Full Text] [Related]
22. Contribution of bioinformatics prediction in microRNA-based cancer therapeutics.
Banwait JK; Bastola DR
Adv Drug Deliv Rev; 2015 Jan; 81():94-103. PubMed ID: 25450261
[TBL] [Abstract][Full Text] [Related]
23. Early detection of cancer: past, present, and future.
Schiffman JD; Fisher PG; Gibbs P
Am Soc Clin Oncol Educ Book; 2015; ():57-65. PubMed ID: 25993143
[TBL] [Abstract][Full Text] [Related]
24. Proteomics of cancer of hormone-dependent tissues.
Tyson DR; Ornstein DK
Adv Exp Med Biol; 2008; 630():133-47. PubMed ID: 18637489
[TBL] [Abstract][Full Text] [Related]
25. Detection of Early Cancer: Genetics or Immunology? Serum Autoantibody Profiles as Markers of Malignancy.
Poletaev A; Pukhalenko A; Kukushkin A; Sviridov P
Anticancer Agents Med Chem; 2015; 15(10):1260-3. PubMed ID: 26179267
[TBL] [Abstract][Full Text] [Related]
26. Salivary biomarkers in cancer detection.
Wang X; Kaczor-Urbanowicz KE; Wong DT
Med Oncol; 2017 Jan; 34(1):7. PubMed ID: 27943101
[TBL] [Abstract][Full Text] [Related]
27. Biomarker profiling for cancer diagnosis, prognosis and therapeutic management.
Mitra AP; Lin H; Cote RJ; Datar RH
Natl Med J India; 2005; 18(6):304-12. PubMed ID: 16483031
[TBL] [Abstract][Full Text] [Related]
28. Droplet-based digital PCR and next generation sequencing for monitoring circulating tumor DNA: a cancer diagnostic perspective.
Postel M; Roosen A; Laurent-Puig P; Taly V; Wang-Renault SF
Expert Rev Mol Diagn; 2018 Jan; 18(1):7-17. PubMed ID: 29115895
[TBL] [Abstract][Full Text] [Related]
29. Coupling Micro-Physiological Systems and Biosensors for Improving Cancer Biomarkers Detection.
Brancato V; Reis RL; Kundu SC
Adv Exp Med Biol; 2022; 1379():307-318. PubMed ID: 35760997
[TBL] [Abstract][Full Text] [Related]
30. Advances, challenges, and limitations in serum-proteome-based cancer diagnosis.
Ebert MP; Korc M; Malfertheiner P; Röcken C
J Proteome Res; 2006 Jan; 5(1):19-25. PubMed ID: 16396491
[TBL] [Abstract][Full Text] [Related]
31. Development and validation of risk models and molecular diagnostics to permit personalized management of cancer.
Pu X; Ye Y; Wu X
Cancer; 2014 Jan; 120(1):11-9. PubMed ID: 24114238
[TBL] [Abstract][Full Text] [Related]
32. Consensus statements from the Second International Lung Cancer Molecular Biomarkers Workshop: a European strategy for developing lung cancer molecular diagnostics in high risk populations.
Field JK; Brambilla C; Caporaso N; Flahault A; Henschke C; Herman J; Hirsch F; Lachmann P; Lam S; Maier S; Montuenga LM; Mulshine J; Murphy M; Pullen J; Spitz M; Tockman M; Tyndale R; Wistuba I; Youngson J
Int J Oncol; 2002 Aug; 21(2):369-73. PubMed ID: 12118333
[TBL] [Abstract][Full Text] [Related]
33. Proteomics biomarkers for solid tumors: Current status and future prospects.
Belczacka I; Latosinska A; Metzger J; Marx D; Vlahou A; Mischak H; Frantzi M
Mass Spectrom Rev; 2019 Jan; 38(1):49-78. PubMed ID: 29889308
[TBL] [Abstract][Full Text] [Related]
34. Emerging technologies for salivaomics in cancer detection.
Kaczor-Urbanowicz KE; Martín Carreras-Presas C; Kaczor T; Tu M; Wei F; Garcia-Godoy F; Wong DT
J Cell Mol Med; 2017 Apr; 21(4):640-647. PubMed ID: 27862926
[TBL] [Abstract][Full Text] [Related]
35. The Role of Epigenomics in the Study of Cancer Biomarkers and in the Development of Diagnostic Tools.
Verma M
Adv Exp Med Biol; 2015; 867():59-80. PubMed ID: 26530360
[TBL] [Abstract][Full Text] [Related]
36. Noncoding RNAs in Cancer Diagnosis.
Zeng MS
Adv Exp Med Biol; 2016; 927():391-427. PubMed ID: 27376744
[TBL] [Abstract][Full Text] [Related]
37. [Structural and functional analysis of tumor genomes and the development of test systems for early diagnosis, prognosis and cancer therapy optimization].
Zaletaev DV; Strel'nikov VV; Nemtsova MV; Babenko OV; Kuznetsova EB; Zemliakova VV; Kekeeva TV; Mikhaĭlenko DS; Tanas AS; Rudenko VV; Babaian AIu; Alekseeva EA; Simonova OA
Vestn Ross Akad Med Nauk; 2013; (9):7-14. PubMed ID: 24624866
[TBL] [Abstract][Full Text] [Related]
38. Lung cancer epigenetics and genetics.
Risch A; Plass C
Int J Cancer; 2008 Jul; 123(1):1-7. PubMed ID: 18425819
[TBL] [Abstract][Full Text] [Related]
39. Cancer Salivary Biomarkers for Tumours Distant to the Oral Cavity.
Rapado-González Ó; Majem B; Muinelo-Romay L; López-López R; Suarez-Cunqueiro MM
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27626410
[TBL] [Abstract][Full Text] [Related]
40. Extracellular miRNAs as biomarkers in cancer.
Barger JF; Rahman MA; Jackson D; Acunzo M; Nana-Sinkam SP
Food Chem Toxicol; 2016 Dec; 98(Pt A):66-72. PubMed ID: 27311798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
